Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Combined With HA in Subjects With Moderate to Severe Chronic Low Back Pain

NCT06325566 is registered in ClinicalTrials.gov with Mesoblast, Ltd. as lead sponsor.

NCT NCT06325566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06325566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Combined With HA in Subjects With Moderate to Severe Chronic Low Back Pain
Lead sponsor
Mesoblast, Ltd.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 3, 2024
Completion date
July 31, 2028
Enrollment
300 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease